Price$275.05-93.22 (-25.31%)
2026-03-042026-06-05
News · 26 weeks72-29%
2025-12-142026-06-07
Mix2290d
- Insider8(36%)
- SEC Filings5(23%)
- Other4(18%)
- Leadership2(9%)
- Earnings2(9%)
- Analyst1(5%)
Latest news
25 items- SECCencora Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cencora, Inc. (0001140859) (Filer)
- SECSEC Form SD filed by Cencora Inc.SD - Cencora, Inc. (0001140859) (Filer)
- INSIDERDirector Durcan Dermot Mark bought $1,065,040 worth of shares (4,000 units at $266.26), increasing direct ownership by 17% to 27,767 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- PRCencora Appoints Eva Boratto as Executive Vice President and Chief Financial OfficerCencora reaffirms fiscal 2026 and long-term financial guidance Cencora, Inc. (NYSE:COR) today announced Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company, effective June 29, 2026. Ms. Boratto succeeds James F. Cleary, who will be retiring from his role as Executive Vice President and Chief Financial Officer as previously announced. Mr. Cleary will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition. Ms. Boratto is an experienced public company executive with considerable financial and operational experience across the healthcare and consumer sectors. She most recently served as Chief Financial Offic
- PRCencora Announces Updated Fiscal Year 2026 Financial OutlookThe Board of Directors authorized a new $2.0 billion share repurchase program Cencora, Inc. (NYSE:COR) today updated its fiscal year 2026 financial guidance as a result of recent opportunistic share repurchases. Cencora now expects adjusted diluted earnings per share to be in the range of $17.70 to $17.90, up from the previous range of $17.65 to $17.90. The opportunistic share repurchases completed in May align with the Company's previously disclosed expectation that it will repurchase $1.0 billion in shares of common stock by the end of calendar 2026. The Company will be participating in upcoming investor discussions in which the updated outlook for fiscal year 2026 will be discussed.
- SECSEC Form 10-Q filed by Cencora Inc.10-Q - Cencora, Inc. (0001140859) (Filer)
- SECCencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cencora, Inc. (0001140859) (Filer)
- PRCencora Reports Fiscal 2026 Second Quarter ResultsRevenue of $78.4 billion for the Second Quarter, a 3.8 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $8.40 and Adjusted Diluted EPS of $4.75 Adjusted Diluted EPS Guidance Range Raised to $17.65 to $17.90 for Fiscal 2026 Cencora Expects to Repurchase $1 Billion in Shares by the End of Calendar 2026 Cencora, Inc. (NYSE:COR) reported that in its fiscal year 2026 second quarter ended March 31, 2026, revenue increased 3.8 percent year-over-year to $78.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $8.40 for the second quarter of fiscal 2026 compared to $3.68 in the prior year second quarter. Adjus
- INSIDERDirector Tyler Lauren M was granted 99 shares, increasing direct ownership by 3% to 3,809 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERDirector Cooper Ellen was granted 99 shares, increasing direct ownership by 14% to 796 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERDirector Nally Dennis M was granted 116 shares, increasing direct ownership by 0.90% to 13,075 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- ANALYSTWilliam Blair initiated coverage on CencoraWilliam Blair initiated coverage of Cencora with a rating of Mkt Perform
- INSIDERSEC Form 4 filed by Krikorian Lazarus4 - Cencora, Inc. (0001140859) (Issuer)
- PRCencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings ReleaseCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 6, 2026. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Financial Officer The live call will be webcast via the Company's website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. To access the call v
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Cencora Inc.SCHEDULE 13G/A - Cencora, Inc. (0001140859) (Subject)
- SECCencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cencora, Inc. (0001140859) (Filer)
- PRCencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina BusinessCencora reaffirms fiscal 2026 financial guidance Cencora, Inc. (NYSE:COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora's Retina Consultants of America ("RCA"), a leading management services organization (MSO). "Driven by a commitment to empower ophthalmologists, EyeSouth Partners has built a strong regional network of physicians that provides high quality patient care," said Robert P. Mauch, President and Chief Executive Officer of Cencora. "By joining RCA, these physicians will become part of an organization
- SECCencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cencora, Inc. (0001140859) (Filer)
- PRCencora Announces Financial Leadership TransitionCencora reaffirms fiscal 2026 financial guidance Cencora, Inc. (NYSE:COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition. Mr. Cleary, 62, has served as Cencora's CFO since November 2018. He joined the Company in February 2015, following its acquisition of MWI Veterinary Supply, where he had served as Chief Executive Officer for over a de
- INSIDERExecutive Vice President Battaglia Silvana converted options into 8,415 shares and covered exercise/tax liability with 3,673 shares, increasing direct ownership by 25% to 23,566 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERExecutive Vice President Campbell Elizabeth S converted options into 12,623 shares and covered exercise/tax liability with 5,842 shares, increasing direct ownership by 28% to 30,706 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERChief Financial Officer Cleary James F covered exercise/tax liability with 5,409 shares and converted options into 12,623 shares, increasing direct ownership by 5% to 160,357 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERDirector Cooper Ellen was granted 692 shares, increasing direct ownership by 13,840% to 697 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERDirector Nally Dennis M was granted 655 shares, increasing direct ownership by 5% to 12,959 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
- INSIDERDirector Tyler Lauren M was granted 641 shares, increasing direct ownership by 21% to 3,710 units (SEC Form 4)4 - Cencora, Inc. (0001140859) (Issuer)
COR FAQ
6 questionsWhat does Cencora Inc. do?
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a...Where does COR stock trade?
Cencora Inc. (COR) is listed on NYSE.What sector and industry is COR in?
Cencora Inc. operates in the Health Care sector, Other Pharmaceuticals industry.What are analysts saying about COR?
Cencora Inc. has had 8 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2026-04-28.What companies are similar to COR?
Notable peers in the same industry include MCK (McKesson Corporation), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.), HLF (Herbalife Ltd.). Compare COR side-by-side with any of them on Quantisnow.How can I track COR on Quantisnow?
Quantisnow aggregates Cencora Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COR to receive live email and push alerts on every new disclosure.